Cargando…
Gene therapy of yeast NDI1 on mitochondrial complex I dysfunction in rotenone-induced Parkinson’s disease models in vitro and vivo
PURPOSE: Parkinson's disease (PD) is the second most common neurodegenerative disease without cure or effective treatment. This study explores whether the yeast internal NADH-quinone oxidoreductase (NDI1) can functionally replace the defective mammalian mitochondrial complex I, which may provid...
Autores principales: | Li, Hongzhi, Sun, Bohao, Huang, Yuting, Zhang, Jing, Xu, Xuejing, Shen, Yuqi, Chen, Zhuo, Yang, Jifeng, Shen, Luxi, Hu, Yongwu, Gu, Haihua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8900322/ https://www.ncbi.nlm.nih.gov/pubmed/35255803 http://dx.doi.org/10.1186/s10020-022-00456-x |
Ejemplares similares
-
Comparison of the effect of rotenone and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on inducing chronic Parkinson's disease in mouse models
por: Zhang, Jing, et al.
Publicado: (2022) -
Protection by the NDI1 Gene against Neurodegeneration in a Rotenone Rat Model of Parkinson's Disease
por: Marella, Mathieu, et al.
Publicado: (2008) -
Mitochondrial release of the NADH dehydrogenase Ndi1 induces apoptosis in yeast
por: Cui, Yixian, et al.
Publicado: (2012) -
No Immune Responses by the Expression of the Yeast Ndi1 Protein in Rats
por: Marella, Mathieu, et al.
Publicado: (2011) -
NDI and DAN DNA: Nucleic Acid-Directed
Assembly of
NDI and DAN
por: Ikkanda, Brian A., et al.
Publicado: (2014)